| Literature DB >> 11806726 |
Ian Hutchinson1, Sharon A Jennings, B Rao Vishnuvajjala, Andrew D Westwell, Malcolm F G Stevens.
Abstract
A series of water-soluble L-lysyl- and L-alanyl-amide prodrugs of the lipophilic antitumor 2-(4-aminophenyl)benzothiazoles has been synthesized to address formulation and bioavailability issues related to the desired parenteral administration of the chosen clinical candidate. The prodrugs exhibit the required pharmaceutical properties of good water solubility (in weak acid) and stability at ambient temperature and degradation to free base in vivo. The lysyl-amide of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (NSC 710305, 6d) has been selected for phase 1 clinical evaluation.Entities:
Mesh:
Substances:
Year: 2002 PMID: 11806726 DOI: 10.1021/jm011025r
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446